• SENSEX 80,349.96
    61.58 (+0.08%)
  • BANKNIFTY 55,391.25
    -41.55 (--0.07%)
  • Mazagon Dock
    3,149.70 3,047.00(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Cochin Shipyard
    1,600.40 1,169.00(%)
  • Torrent Pharma.
    3,360.00 3,589.95(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Tata Motors
    642.00 542.55(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Samvardh. Mothe.
    132.05 107.30(%)
  • Data Pattern
    2,459.05 1,350.50(%)
  • Varun Beverages
    507.45 419.40(%)
  • IndusInd Bank
    810.40 605.40(%)
  • Trent
    5,134.00 4,058.45(%)
  • Hitachi Energy
    14,879.00 16,534.50(%)
  • Bharat Electron
    312.50 221.00(%)
  • ICICI Bank
    1,424.00 1,051.50(%)
  • HDFC Bank
    1,936.40 1,977.95(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • Sonata Software
    415.25 762.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Syschem (India) Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 6001.0
  • ISIN : INE121D01036
41.95 2 (5.16%)
  • As on 30 Apr 2025 (EOD)

  • Today’s Low

    40.00

  • Today’s High

    42.38

  • Open

    42.38

  • Perv Close

    39.89

  • 52W Low

    35.33

  • 52W High

    62.50

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    182.54

  • Div & Yield %

    0.00

  • Book Value(₹)

    17.08

  • Debt-Equity Ratio

    5.16

  • AGM Date

    29-Apr-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    182.54

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    43.51

  • BV (₹)

    17.10

  • Sales( ₹ in Cr.)

    233.48

  • NP (in Cr.)

    2.76

  • NP Var(%)

    -39.0

  • Div%

    0.0

  • CPS (₹)

    1.30

  • EPS (₹)

    0.60

  • Traded Value (₹ in Lakhs)

    182.54

  • 52 Week High

    62.50

  • 52 Week Low

    35.33

  • Price BSE

    42.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    182.54

  • P/C Ratio

    32.90

  • P/E Ratio

    66.10

  • Price Vs.BV

    0.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 233.48 130.38 65.63 74.41 88.02 109.60
Excise Duty 0.00 0.00 0.00 0.00 11.09 16.49
Net Sales 233.48 130.38 65.63 74.41 76.93 93.11
Other Income 0.17 0.25 0.13 0.26 0.09 0.08
Stock Adjustments 22.25 -1.12 0.88 -5.44 -1.27 2.30
Total Income 255.90 129.51 66.64 69.23 75.75 95.49
EXPENDITURE :            
Raw Materials 197.91 92.46 46.97 55.42 67.16 85.63
Power and Fuel Cost 2.84 2.15 2.39 2.87 1.89 1.57
Employee Cost 6.08 4.40 4.54 4.10 2.99 2.96
Other Manufacturing Expenses 4.35 2.95 3.46 2.92 1.02 0.16
Selling and Administration Expenses 37.32 18.30 8.41 8.47 1.66 1.00
Miscellaneous Expenses 0.25 0.35 0.18 0.36 1.05 0.51
Employee Benefit Expenses 6.08 4.40 4.54 4.10 2.99 2.96
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 248.75 120.61 65.95 74.14 75.77 91.83
Operating Profit 7.15 8.89 0.69 -4.90 -0.03 3.66
Interest 0.25 0.04 0.28 0.06 0.02 0.01
Gross Profit 6.90 8.85 0.41 -4.96 -0.05 3.65
Depreciation 2.79 2.70 2.58 2.35 2.15 2.15
Profit Before Tax 4.11 6.15 -2.17 -7.31 -2.20 1.50
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.35 1.64 -0.47 -1.75 -0.35 0.75
Reported Net Profit 2.76 4.51 -1.71 -5.57 -1.85 0.75
Extraordinary Items 0.00 0.00 0.00 -0.28 -0.03 -0.25
Adjusted Net Profit 2.76 4.51 -1.71 -5.29 -1.82 1.00
Adjustment below Net Profit 0.00 0.12 0.00 0.00 0.00 0.00
P & L Balance brought forward -13.87 -18.50 -16.79 -11.23 -9.37 -10.12
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -11.10 -13.87 -18.50 -16.79 -11.23 -9.37
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.69 1.42 -0.73 -2.58 -0.99 0.40
Earnings Per Share(Adj)-Unit Curr 0.69 1.30 -0.67 -2.37 -0.91 0.37
Book Value 14.29 6.99 2.60 2.79 4.69 5.68
Book Value(Adj)-Unit Curr 14.29 6.42 2.39 2.56 4.31 5.22

Shareholding Pattern

  • Promoter Group

    57.02%

  • Public Share Holding

    42.98%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 24,811,446 57.02 21,161,446 13
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 24,811,446 57.02 21,161,446 13
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 80,000 0.18 80,000 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 80,000 0.18 80,000 1
2] Non Institution
Bodies Corporate 2,728,072 6.27 2,696,972 112
Clearing Members 1,000 0.00 1,000 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 356,069 0.82 198,869 245
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,017,988 2.34 1,017,988 255
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,351,424 16.89 7,351,424 96
Individuals holding nominal share capital up to Rs. 1 lakh 7,167,001 16.47 7,065,699 12,500
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 18,621,554 42.80 18,331,952 13,209
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 43,513,000 100.00 39,573,398 13,223

Company Background

Syschem (India) LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Syschem (India) Ltd
  • BSE Code : 6001.0
  • ISIN : INE121D01036

  • Incorporation Year

    1993

  • Registered Office

    Tehsil Kalka
    Bargodam Village, Panchkula,
    Haryana-133302

  • Telephone

    91-172-3077777

  • FAX

    91-172-3077700

  • Chairman

  • Managing Director

  • Company Secretary

    Shikha Kataria

  • Auditor

    STAV & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Beetal Fin.& Comp. Ser.(P) Ltd
    Beetal House 99 ,
    Madangir Behind LSC ,Nr Dada Harsukhdar
    Mumbai - Delhi - 110062

Syschem (India) Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Syschem (India) 41.95 233.65 233.48 -699.17 6.14
Abbott India 30,094.35 6,097.18 5,848.91 47.92 44.71
Astrazeneca Phar 8,795.90 1,330.33 1,295.53 226.76 33.26
P & G Health Ltd 5,121.00 1,166.89 1,151.26 35.93 39.76
Glaxosmi. Pharma 2,904.45 3,530.73 3,407.25 57.75 44.44
Cipla 1,541.00 17,645.00 16,574.34 26.42 20.10
Amrutanjan Healt 679.10 437.58 421.23 39.81 20.84
Guj. Themis Bio. 285.15 174.19 169.82 59.04 44.82
Fermenta Biotec. 272.25 315.24 307.09 25.81 4.10
Bliss GVS Pharma 122.65 638.96 605.46 28.07 11.19
Ambalal Sarabhai 37.10 11.70 3.81 15.85 1.92